Presentations
Author: Amanda Gibson et al.
Real-world (TW) Genomic Landscape, PARP-inhibitor (PARPi) Treatment Patterns and Adverse Events (AE) in Advanced Prostate Cancer: The National CanaDNA Study
Author: Kelly Gao et al.
Development of a Novel Risk Stratification Model for Immune-Related Adverse Events for Patients with Advanced Melanoma and Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
Author: Amanda Gibson et al.
Real world outcomes in extensive stage small cell lung cancer (ES-SCLC) treated with consolidative thoracic radiation (cTRT) and chemoimmunotherapy (CIT): A population level study.